Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2332149
Max Phase: Preclinical
Molecular Formula: C12H22N2O
Molecular Weight: 210.32
Molecule Type: Small molecule
Associated Items:
ID: ALA2332149
Max Phase: Preclinical
Molecular Formula: C12H22N2O
Molecular Weight: 210.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC(=O)N[C@H]1CCCN2CCCC[C@H]12
Standard InChI: InChI=1S/C12H22N2O/c1-2-12(15)13-10-6-5-9-14-8-4-3-7-11(10)14/h10-11H,2-9H2,1H3,(H,13,15)/t10-,11+/m0/s1
Standard InChI Key: LHQNLHGTLICUHG-WDEREUQCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 210.32 | Molecular Weight (Monoisotopic): 210.1732 | AlogP: 1.53 | #Rotatable Bonds: 2 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.68 | CX LogP: 1.29 | CX LogD: -0.01 |
Aromatic Rings: 0 | Heavy Atoms: 15 | QED Weighted: 0.75 | Np Likeness Score: -0.62 |
1. Tasso B, Novelli F, Sparatore F, Fasoli F, Gotti C.. (2013) (+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype., 76 (4): [PMID:23461628] [10.1021/np3007028] |
Source(1):